Objectives: To evaluate the accuracy of serum amyloid A (SAA), an acute phase protein in the detection of neonatal early-onset sepsis, by means of a fast automated SAA kit.
Introduction
Neonatal early-onset sepsis (EOS) in the era of perinatal antibiotic treatment has become an infrequent event occurring in 1 to 5 per 1000 live births; nevertheless it carries a high risk of mortality and morbidity. 1 Because of the nonspecific signs, the clinical diagnosis of sepsis in neonates is difficult to determine. Furthermore, blood cultures that are the ultimate tool for its diagnosis have a sensitivity of 50 to 80% in neonatal EOS. 2 There are few adjunctive, nonspecific, diagnostic-screening tests helping the clinician to identify newborns suffering from EOS. Acute phase reactants such as C-reactive protein (CRP) and cytokines, for example, interleukin (IL)-6, IL-8, and tumor necrosis factor alpha (TNF-a), have been shown to correlate with the diagnosis of EOS. 1 However, CRP appears to be less sensitive at onset of sepsis, and cytokines owing to their short half-life are less sensitive after 12 and 24 h of onset of sepsis, thus increasing the risk of false-negative results. 3 Procalcitonin, an early marker of bacterial infection, seems to be a valuable addition to the current diagnostic workup of EOS. However, most studies investigating this early marker of neonatal EOS concluded that procalcitonin is not better than CRP in assessing EOS and that its diagnostic accuracy is complicated by a physiological increase during the first days of life. 4 Several studies, analyzing term infants suspected of sepsis, have recently shown that inflammatory markers such as whole-blood IL-8 and neutrophil CD64 are very sensitive indicators of EOS in a research setting, [5] [6] yet because of special handling requirements, they are not readily available in hospital laboratories.
Serum amyloid A (SAA), an acute-phase reactant was shown to be useful in various acute diseases (bacterial, viral, traumatic, rheumatic and ischemic heart disease). [7] [8] Liberatori et al., 9 analyzing four preterm and four full-term infants with EOS, showed that SAA levels rise, peak and decline in spot intensity as expected for acute phase protein. It was also shown that SAA has a better diagnostic accuracy than CRP and can be used in routine clinical work to diagnose, follow-up, and predict the outcome of late-onset sepsis in preterm infants. [10] [11] [12] Therefore, we aimed to evaluate the diagnostic accuracy of SAA in neonatal EOS at 0 and 24 h after birth. A comparison was drawn between the dynamics of SAA and CRP, an acute phase protein commonly used in EOS, and their association with the clinical course during the 48 h of EOS in term infants.
Methods

Study population
Six-thousand five-hundred and sixty infants consecutively admitted to the Neonatal Department of Meir Medical Center (Kfar Saba, Israel) over a 16-month period (ended March 2005) with gestational age of 37 weeks or more were prospectively screened for sepsis. One-hundred and twenty infants had pre-, peri-, or postnatal risk factors and/or were suspected of having sepsis. Excluded were five infants with congenital abnormalities that mimic EOS. Three parents refused participation. In three infants data were insufficient for analysis and in additional five infants blood was taken at inappropriate time points. Thus, the final number of infants available for sepsis evaluation was 104.
Recruited for study were also a control group of 30 well-term infants, matched for gestational age (P ¼ 0.76) and mode of delivery (P ¼ 0.59), whose blood was taken in intervals of 24 h for jaundice follow-up. They served as controls for comparing SAA concentrations.
The study protocol was approved by the Institutional Review Board of Meir Medical Center and a written informed consent form was obtained from all parents.
Initial screening criteria suggestive of EOS Infants were suspected of having neonatal EOS if the following clinical and laboratory risk factors suggestive of sepsis were found: (1) a diagnosis of maternal infection at the time of the delivery based on the presence of maternal temperature elevation X381C (after exclusion of infectious foci unrelated to the fetus) and accompanied by at least one of the following clinical signs (2) foul smelling amniotic fluid, (3) positive placental cultures, (4) fetal tachycardia (>160 beats per min), and (5) prolonged rupture of membranes for more than 18 h.
Neonatal clinical and laboratory criteria suggestive of EOS were as follows: (1) temperature instability (<36.51C or > 37.51C) on two occasions within 6 h; (2) pallor; (3) poor skin perfusion (capillary refill >3 s); (4) respiratory distress (tachypnea >60 respirations per min at rest and/or dyspnea (retractions, nasal flaring, grunting)); (5) apnea (no inspiratory gas flow for 20 s or shorter associated with bradycardia (<100 beats per min), cyanosis or pallor); (6) need for oxygen; (7) lethargy or irritability; (8) hypotension (systolic blood pressure <50 mm Hg); (9) muscular hypotonia; (10) persistent vomiting; (11) abdominal distention; (12) leukocytosis (white blood cell (WBC) count >34 000 Â 10 9 /l); (13) leukopenia (WBC count <5000 Â 10 9 /l); (14) immature neutrophils >10%; (15) immature to total neutrophil ratio >0.2; (16) thrombocytopenia <100 000 Â 10 9 /l; (17) hyperglycemia (glucose concentrations >180 mg/dl); and (18) hypoglycemia (glucose concentrations <40 mg/dl).
The concentrations of SAA and CRP, clinical and biochemical parameters and blood cultures were taken at 0 24, and 48 h postsepsis evaluation. Chest X-ray and lumbar puncture for cerebrospinal fluid (CSF) analysis were done on every symptomatic infant.
Definition of early-onset sepsis
The definition of EOS was based on a positive blood culture and the presence of clinical and biochemical signs suggestive of sepsis (i.e., proven sepsis). When blood culture was negative, definition of EOS was based on the presence of clinical signs and symptoms of infection and at least two abnormal laboratory results (i.e., clinical sepsis). 13 The detection of coagulase-negative staphylococcus required cultures from two sites. Meningitis was diagnosed when spinal fluid grew bacteria. Early-onset pneumonia was diagnosed when respiratory distress was detected shortly after birth and was associated with coarse opacities in two consecutive chest radiographs interpreted by a consultant radiologist. The diagnosis of EOS was made by the attending neonatologist in a blinded fashion, not knowing the levels of SAA.
In accordance with the definition of EOS, infants who met the screening criteria outlined earlier were divided into septic (either proven sepsis or clinical sepsis) and nonseptic (who ultimately did not meet the definition of EOS) groups.
Processing and measurement of serum amyloid A and C-reactive protein Levels of SAA, using only 3 ml of serum for the SAA test, and other biochemical parameters determined from the same sampling immediately after blood were drawn. The automated latex photometric immunoassay agglutination reaction LZ TEST 'Eiken' SAA (Eiken Chemical Co. Ltd, Tokyo, Japan) was adapted to Hitachi 917 14 by using two points reaction during 10 min and absorbance at 660 mu. The first reagent included the reaction buffer, whereas the second included the latex suspension. The latter was sensitized with antihuman SAA rabbit polyclonal antibody and antihuman SAA mouse monoclonal antibody. The tested SAA produced an agglutination-antigen-antibody reaction, in which agglutination was proportional to SAA concentration in the serum. The reaction range was between 0 and 386 mg/ml and the within-run precision was <10%. There was no interference from bilirubin (<25 mg/dl), hemoglobin or lipids. Tina-quant immunoturbidimetric assay in human serum (Roche/Hitachi 917 modular package, high sensitive CRP) was used for in vitro quantitative determination of CRP with a normal range of <10 mg/l.
Statistical analysis
The analysis was performed with the statistical package SPSS for Windows version 14.0. (SPSS Inc. 2003, Chicago, IL, USA). Data are presented as mean (±s.d.) or median (interquartile range) and compared using unpaired Student's t-test or one-way analysis of variance (ANOVA) test when appropriate for distribution normality. Categorical data were analyzed using the Pearson's w 2 test. The Mann-Whitney U test was performed to test for significant differences in the concentrations of SAA and CRP between the septic and the nonseptic groups. Measures of diagnostic accuracy of SAA and CRP for the detection of neonatal EOS (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR þ ), and negative likelihood ratio (LRÀ) were calculated only for infants suspected of having sepsis. The area under the receiver operator characteristic (ROC) curve was estimated. Optimal cutoff points were chosen to allow high sensitivity and high specificity (i.e., low false-positive) of the results. A multivariable regression analysis was performed to determine the relative contribution of the explanatory variables, including having vs not having sepsis, mode of delivery, sepsis evaluation time, gestational age, Apgar scores and maternal fever on SAA concentration. Statistical significance was set at P<0.05.
Results
One-hundred and four of the initially screened infants (n ¼ 6560) met the inclusion criteria for EOS. Of whom 23 (0.35%) were diagnosed with sepsis. Eleven had proven sepsis (six had positive blood cultures for Streptococcus group B, four for Escherichia Coli and one for Staphylococcus aureus) and 12 had clinical sepsis. The treatment regimen consisted of antibiotics for 7 to 10 days. The remaining 81 infants, matching the screening criteria for EOS, had no sepsis and antibiotic treatment was stopped 48 to 72 h from sepsis evaluation with no clinical deterioration. Seventeen infants had transient tachypnea of the newborn, seven had apnea and desaturation, five had gastroesophageal reflux, four had meconium aspiration syndrome, three had persistent pulmonary hypertension and the remaining 45 had risk factors or signs of EOS but did not fit the definition for neonatal sepsis. All infants of the study group had no pneumonia and CSF cultures were negative. No deaths were recorded in this series.
Postnatal age of sepsis evaluation was not different between both clinical and proven sepsis subgroups and the nonseptic group (4.8±1.84, 5.04±1.24 and 5.1±2.21 h, respectively; P>0.1). Analysis by gestational age, birth weight, mode of delivery, multiple birth and Apgar scores after 1 and 5 min (Table 1) showed no statistical difference between the septic, nonseptic and control groups. All prenatal risk factors and most clinical signs suggestive of EOS could not differentiate between the septic and nonseptic groups, or between proven and clinical sepsis except for muscular hypotonia that was significantly higher in both septic subgroups compared with the nonseptic group (P<0.05). A comparison between laboratory parameters suggestive of EOS also showed that hyperglycemia, and I/T neutrophil >0.2 were significantly more common in the septic group as compared with the nonseptic group (P<0.05 for both parameters). However, muscular hypotonia, hyperglycemia and I/T neutrophil count >0.2 were present only in 54, 19 and 45%, respectively, of the infants with sepsis. The biochemical parameters of infants with clinical and proven sepsis were also not different from each other (P>0.05).
The time course of CRP and SAA are shown in Figure 1 . SAA levels of the septic group compared with that of the nonseptic group were significantly elevated at 0, 24 and 48 h (P<0.01 for the three time points), reaching maximal values at 24 h and declining towards baseline values concomitant with clinical improvement. Compared with CRP, SAA levels rose earlier and in a sharper manner, had higher levels, and returned faster to normal values in infants with EOS. A continuous low concentration of SAA was shown in the control group. Separate analysis of SAA and CRP levels in proven and clinical sepsis did not demonstrate significant differences between these two groups (P ¼ 0.33). No difference was found between the nonseptic and the control groups (P ¼ 0.1).
In the multivariable regression analysis, the SAA levels at 0, 24 and 48 h post-sepsis onset were independently affected by having vs not having sepsis (R 2 was 0.720, 0.705 and 0.518 for the different time points, respectively; P<0.001), but not by mode of delivery, sepsis evaluation time, gestational age, Apgar scores and maternal fever (P>0.05 for all variables).
The ROC curves showed that the optimal cutoff value for maximal sensitivity of SAA in infants suspected of having sepsis (both septic and nonseptic groups) was 8 mg/l at 0 and 10 mg/l at 24 h post-sepsis evaluation. The optimal cutoff value for CRP was 7 mg/l both at 0 and 24 h post-sepsis evaluation. When compared with CRP, SAA had the largest area under the curve (AUC) with significantly higher levels at 0 h (SAA (AUC, 0.987; 95% CI, 0.97 to 1.00); CRP (AUC, 0.843; 95% CI, 0.72 to 0.96; P<0.01)) but not at 24 h (SAA (AUC, 0.997; 95% CI, 0.99 to 1.00); CRP (AUC, 0.998; 95% CI, 0.99 to 1.00; P>0.05)). SAA also had a higher sensitivity, NPV, LR þ and LRÀ than CRP at sepsis onset (0 h). At 24 h after sepsis onset, SAA had the same accuracy as CRP in detecting sepsis ( Table 2) .
Discussion
Recognition of EOS is a daily dilemma for clinicians because of the nonspecific presenting signs of most infected newborns. Although muscular hypotonia, hyperglycemia, and I/T neutrophil count SAA for neonatal early-onset sepsis S Arnon et al >0.2 were significantly more common in the septic group, these signs were present only in 52, 16 and 44%, respectively, of the infants with sepsis and were not sensitive and specific enough to discern between those who had developed sepsis and those who had not. CRP is an acute phase reactant that is commonly used in the evaluation of EOS, but it is not sensitive enough to confirm the diagnosis at the early stage of infection in neonates; therefore it is used in combination with other early markers of infection such as IL-6 and IL-8. 3, 15 However, taking into account the short half-life and the decreased sensitivity of ILs after 12 to 24 h from the onset of infection, there is an increased risk of false-negative results.
SAA is known as an accurate inflammatory marker for the diagnosis and follow-up of late-onset sepsis in preterm infants [9] [10] [11] and has a greater sensitivity and specificity in reflecting inflammatory states. [16] [17] [18] We found that SAA has a high sensitivity and NPV at the time of sepsis evaluation, therefore can be used as a sensitive marker for the detection of EOS, not missing genuine cases of EOS when levels of SAA remain low. Compared with CRP, SAA was more sensitive at onset of sepsis, rose earlier and in a sharper manner, had higher levels and returned faster to normal values in infants who recovered, allowing an accurate and quick diagnosis of EOS. Because there is no transplacental transfer of SAA and CRP during labor, 19 their high levels after birth represent showed that vaginal compared with Caesarian-section delivery might elicit acute phase response in the neonate and causing elevation of SAA to a median level of 4.2 mg/l at around 24 h after birth. However, these levels are much lower than those found in our septic group and are diluted in the response elicited by sepsis. Furthermore, we did not find a relationship between mode of delivery and levels of SAA or CRP in the septic, nonseptic and control groups. The mechanism responsible for the different response of SAA and CRP to infectious stimuli is as yet unknown. However, as the major stimulus for the secretion of SAA are many proinflammatory cytokines such as IL-1, IL-6, IL-8 and TNF-a, 21 it is assumed that measuring SAA can give us an indication of the total effect of all the inflammatory cytokines that individually can induce the production of SAA. The finding that SAA specifically activates polymorphonuclear antimicrobial function by inducting degranulation, phagocytosis and enhancement of anticandidal activity, 22 can partially explain the differences in the dynamics of SAA and CRP.
A prominent issue in the detection and treatment of EOS is the presence of positive blood cultures. We included in the septic group term infants with clinical signs and laboratory parameters of infection, who lacked positive blood cultures for EOS. Given that a negative culture does not always refute a diagnosis of EOS and that the sensitivity of blood cultures is only 50 to 80%, especially in neonates whose mothers were treated with prophylactic antibiotics, 1 incorporating this group into the definition of sepsis is relevant to real-life circumstances.
No comparison was made between SAA and other inflammatory markers in use such as procalcitonin or cytokines, which were shown to be very reliable in combination with CRP to detect EOS and to reduce unnecessary antibiotic treatment. 15 Because SAA rise early in the course of EOS and is triggered by many cytokines, it might be added to other markers in detecting EOS.
In summary, SAA an inflammatory marker of neonatal EOS had an overall better diagnostic accuracy than C-reactive at 0 h post-sepsis evaluation. It can be easily and rapidly performed in every service laboratory and used as a reliable tool for the detection of neonatal EOS in full-tern infants. SAA for neonatal early-onset sepsis S Arnon et al
